PAMP
Polar Asset Management Partners Portfolio holdings
AUM
$4.01B
1-Year Return
16.83%
This Quarter Return
+5.9%
1 Year Return
+16.83%
3 Year Return
+58.06%
5 Year Return
+77.6%
10 Year Return
+137.41%
AUM
$4.18B
AUM Growth
+$265M
(+6.8%)
Cap. Flow
-$1.16B
Cap. Flow
% of AUM
-27.7%
Top 10 Holdings %
Top 10 Hldgs %
22.7%
Holding
913
New
192
Increased
86
Reduced
128
Closed
185
Top Buys
Top Sells
| 1 |
AMK
AssetMark Financial Holdings, Inc.
AMK
|
$50.7M |
| 2 |
Intuitive Surgical
ISRG
|
$39.4M |
| 3 |
TransUnion
TRU
|
$32.2M |
| 4 |
Boston Scientific
BSX
|
$30.1M |
| 5 |
ServiceNow
NOW
|
$25.8M |
Sector Composition
| 1 | Technology | 14.84% |
| 2 | Healthcare | 12.55% |
| 3 | Industrials | 9.03% |
| 4 | Financials | 7.28% |
| 5 | Communication Services | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Nurix Therapeutics
NRIX
$758M
| $607K | 0.01% |
+27,000
| New | +$607K |
|
|
HAYN
402
DELISTED
Haynes International, Inc.
HAYN
| $595K | 0.01% |
10,000
+2,500
| +33% | +$149K |
|
403
Tevogen Bio Holdings
TVGN
$170M
| $581K | 0.01% |
1,577,387
-408,228
| -21% | -$150K |
|
404
Repligen
RGEN
$7.01B
| $580K | 0.01% |
+3,900
| New | +$580K |
|
|
CSLM
405
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
| $570K | 0.01% |
50,000
-150,000
| -75% | -$1.71M |
|
406
Erasca
ERAS
$457M
| $547K | 0.01% |
200,300
-63,200
| -24% | -$173K |
|
407
Lexeo Therapeutics
LXEO
$271M
| $541K | 0.01% |
59,800
-5,500
| -8% | -$49.7K |
|
|
AITR
408
DELISTED
AI TRANSPORTATION ACQUISITION CORP Ordinary shares
AITR
| $524K | 0.01% |
50,000
| – | – |
|
409
Absci
ABSI
$368M
| $523K | 0.01% |
+137,000
| New | +$523K |
|
410
Guardant Health
GH
$7.5B
| $521K | 0.01% |
22,700
-111,300
| -83% | -$2.55M |
|
411
TransAlta
TAC
$3.64B
| $518K | 0.01% |
+50,000
| New | +$518K |
|
412
Beam Therapeutics
BEAM
$2.11B
| $510K | 0.01% |
+20,800
| New | +$510K |
|
413
BlackRock Science and Technology Trust
BST
$1.37B
| $507K | 0.01% |
+14,300
| New | +$507K |
|
414
Rogers Communications
RCI
$19.4B
| $503K | 0.01% |
12,518
-11,693
| -48% | -$470K |
|
415
BCE
BCE
$23.1B
| $498K | 0.01% |
+14,309
| New | +$498K |
|
416
Mineralys Therapeutics
MLYS
$2.7B
| $490K | 0.01% |
+40,500
| New | +$490K |
|
|
BLDP
417
Ballard Power Systems
BLDP
$598M
| $485K | 0.01% |
270,000
+120,000
| +80% | +$216K |
|
418
CarParts.com
PRTS
$60.1M
| $483K | 0.01% |
533,212
-500,000
| -48% | -$453K |
|
|
RVNC
419
DELISTED
Revance Therapeutics, Inc.
RVNC
| $467K | 0.01% |
+90,000
| New | +$467K |
|
420
Intellia Therapeutics
NTLA
$1.29B
| $466K | 0.01% |
22,700
-22,500
| -50% | -$462K |
|
421
Regeneron Pharmaceuticals
REGN
$60.8B
| $420K | 0.01% |
400
-900
| -69% | -$946K |
|
422
Lightspeed Commerce
LSPD
$1.65B
| $412K | 0.01% |
+25,000
| New | +$412K |
|
|
ABVX
423
Abivax
ABVX
$6.65B
| $402K | 0.01% |
34,939
-18,300
| -34% | -$211K |
|
424
Scholar Rock
SRRK
$3.02B
| $389K | 0.01% |
48,600
| – | – |
|
425
Albertsons Companies
ACI
$10.7B
| $370K | 0.01% |
+20,000
| New | +$370K |
|